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In mammals, peroxisomes perform crucial functions in cellular metabolism, signalling and viral defense which are essential to the health and viability of the organism. In order to achieve this functional versatility peroxisomes dynamically respond to molecular cues triggered by changes in the cellular environment. Such changes elicit a corresponding response in peroxisomes, which manifests itself as a change in peroxisome number, altered enzyme levels and adaptations to the peroxisomal structure. In mammals the generation of new peroxisomes is a complex process which has clear analogies to mitochondria, with both sharing the same division machinery and undergoing a similar division process. How the regulation of this division process is integrated into the cell’s response to different stimuli, the signalling pathways and factors involved, remains somewhat unclear. Here, we discuss the mechanism of peroxisomal fission, the contributions of the various division factors and examine the potential impact of post-translational modifications, such as phosphorylation, on the proliferation process. We also summarize the signalling process and highlight the most recent data linking signalling pathways with peroxisome proliferation. 
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Highlights: 
•	Pex11β plays a role in membrane remodelling and as a GTPase activator of DLP1. 
•	Phosphorylation of peroxisomal proteins may regulate peroxisome proliferation.
•	Peroxisomal division proteins may modulate division under different settings.
•	Peroxisome proliferation involves both PPAR dependent and independent mechanisms.

Abbreviations:
ER, endoplasmic reticulum; GC, glucocorticoid; GREs, glucocorticoid response element; GR, glucocorticoid receptor; mTOR, mammalian target of rapamycin; ORE, oleate response elements; PBD, peroxisome biogenesis disorder; PEX, peroxin; PPAR, peroxisome proliferator-activated receptor; PPRE, peroxisome proliferator response element; PTS, peroxisomal targeting signal; ROS, reactive oxygen species.

1. Introduction
Peroxisomes are ubiquitous, multifunctional and dynamic organelles, which are indispensable for human health and development. Peroxisomes make important contributions to cellular ROS metabolism and lipid homeostasis. In mammals, they are also involved in plasmalogen biosynthesis and the synthesis of bile acids, mediators of inflammation (e.g. leukotrienes) and docosahexaenoic acid (DHA), and a modulator of neuronal function (). To perform their multiple metabolic tasks, peroxisomes cooperate with several other subcellular compartments including mitochondria, ER, lipid droplets or lysosomes  ADDIN EN.CITE (; ; ). In addition, peroxisomes represent important intracellular signalling platforms in redox-, lipid-, inflammatory-, and antiviral signalling  ADDIN EN.CITE (; ; ). As dynamic organelles, peroxisomes have the capability to proliferate in response to environmental stimuli and are degraded to maintain default numbers when the stimuli dissipate. Accordingly, control of peroxisome number can only be achieved through tight regulation of peroxisome formation (biogenesis) and degradation (pexophagy)  ADDIN EN.CITE (; ; ). Regarding peroxisome biogenesis two mechanisms have been described: (i) by growth and asymmetric division of pre-existing organelles  ADDIN EN.CITE (; ; ); (ii) de novo formation from the endoplasmic reticulum  ADDIN EN.CITE () (see Chapters by Kim and van der Klei & Veenhuis, this issue). The mechanism of growth and division of peroxisomes is initiated by a membrane remodelling process and regulated by peroxisomal morphology proteins such as Pex11, DLP1/Drp1, Fis1, Mff, and GDAP1 which, with the exception of Pex11, are partially shared with mitochondria (see section 4). Mutations in some of the genes encoding for key division factors have now been linked to novel disorders which mainly affect peroxisome dynamics but not metabolism (see sections 4.2 and 4.5)  ADDIN EN.CITE (; ). Thus far, it is still puzzling how both biogenesis mechanisms operate to maintain peroxisome number in mammalian cells. Here, we discuss the current understanding of the mechanisms of peroxisome formation by growth and division and highlight recent advancements in the field. 
Peroxisome proliferation is coordinated by signalling cascades occurring in the nucleus where transcription factors can enhance the expression of peroxisomal genes (Fig. 1). These signalling pathways are usually initiated by external stimuli such as fatty acids or fibrates and lead to an increase in peroxisome number (usually termed “peroxisome proliferation”)  ADDIN EN.CITE (; ). Despite the importance of signalling in peroxisome proliferation, information on different signalling pathways inducing peroxisome proliferation in mammals is relatively fragmentary. However, in the yeast S. cerevisiae, where the transcriptional control systems are somewhat less complex and fatty acid β-oxidation only occurs in peroxisomes, they have been extensively studied. ScPip2 and ScOaf1p are two transcription factors that heterodimerize upon stimulation and bind to oleate response elements (OREs) in the promoter region of peroxisomal genes, activating their transcription. ScOaf1p is an oleate-activated transcription factor and possesses functional fatty acid-binding domains (). Other ascomycetes have independently evolved a system for the transcriptional control of peroxisomal genes: the Far-nuclear receptors, FarA and FarB  ADDIN EN.CITE (). The transcriptional activity of FarA and FarB is induced by binding long and medium chain fatty acids respectively, resulting in up-regulation of proliferation related genes. In plants, peroxisome proliferation can be induced by ROS, UV irradiation, light and salt stress which requires the activation of the far-red light receptor phyA, as well as the bZIP transcription factor HYH, which binds directly to the promoter of peroxisomal genes, e.g. PEX11  ADDIN EN.CITE (; ). The major pathway in mammals is the peroxisome proliferator-activated receptor α (PPAR) dependent pathway  ADDIN EN.CITE (; ), but there is also growing evidence for PPAR-independent systems which can be activated by extracellular signals such as ROS and growth factors  ADDIN EN.CITE (; ). As PPARα signalling has been extensively reviewed previously  ADDIN EN.CITE (), we will give a brief overview and focus on more recent discoveries.

2. Regulation of peroxisome proliferation in mammals
2.1. The PPAR protein family




Fig. 1. Signalling pathways that trigger peroxisome proliferation in mammals. 
(A) Extra- or intracellular signalling molecules such as growth factors, hypolipidemic compounds, ROS or fatty acids bind to specific nuclear receptors (e.g. PPARα) leading to PPAR-dependent and potentially to PPAR-independent signalling pathways. (B) In the PPAR-dependent pathway, binding of activating ligands to PPARs and to its partner RXR induce conformational changes of the receptors resulting in transcriptional complex formation. Activation of the transcriptional complex occurs upon transcriptional cofactor binding, which then allows binding to PPREs in peroxisomal genes to initiate gene expression. PPAR-independent mechanisms have also been described which may signal through as yet unidentified receptors (indicated by “?”)  ADDIN EN.CITE (). (C) Expression of peroxisomal biogenesis factors (e.g. Pex11) and/or β-oxidation enzymes can promote peroxisome proliferation and/or increased fatty acid metabolism. Peroxisome proliferation is initiated by membrane remodelling followed by a multi-step process of membrane elongation (growth), constriction and final membrane scission. These processes are mediated by division proteins (e.g. Pex11β, Fis1, Mff and DLP1) (see section 4 and Fig. 2 for further details).

2.2. PPARα
Evidence of peroxisome proliferation (i.e. increase in number) in mammals in response to specific stimuli was first described in 1965 by Hess and co-workers, who treated rats with the fibrate ethyl-chlorophenoxy-isobutyrate (). Since then, it has been shown that ethyl-chlorophenoxy-isobutyrate and other fibrates (such as bezafibrate, fenofibrate, Wy-14,643 and clofibrate) are PPARα agonists and can significantly increase peroxisome number and the levels of fatty acid β-oxidation enzymes  ADDIN EN.CITE (; ; ). Surprisingly, the effect of these compounds in peroxisome proliferation is, in mammals, apparently restricted to the superfamily of Muroidea, whereas in humans the effect is very mild  ADDIN EN.CITE (; ). 
In humans, PPARα plays a role in the regulation of lipid and glucose homeostasis and inflammatory responses (). Using ChiP-seq analysis in human hepatoblastoma (HepG2) cells several genes have been shown to bear PPREs suggesting they are regulated by PPARα, such as ACOX1, ACADs (acyl-CoA dehydrogenases) and G0S2 (G0/G1 Switch Regulatory Protein 2) (). This is supported by studies with the synthetic PPAR activator GW7647 which demonstrate that ACAD and ACOX1 are up-regulated upon treatment with this PPARα agonist  ADDIN EN.CITE (; ). Among other slightly up-regulated genes in primary human hepatocytes treated with GW7647, are metabolism related genes such as PLIN1 (Perilipin 1), PDK4 (Pyruvate Dehydrogenase Kinase, Isozyme 4), as well as PEX11α, highlighting the role of this pathway in regulating expression of genes involved in lipid metabolism  ADDIN EN.CITE (). However the mechanism by which PPARα signalling could stimulate an increase in peroxisome numbers in humans remains somewhat controversial. It has been established that one of the major factors involved in proliferation is Pex11β (see section 4.1 for details) () and currently there is no evidence for up-regulation of Pex11β following stimulation with PPARα agonists.  
As well as activation by fibrates other stimuli have recently been identified which involve PPARα directly or cross-talk with the PPARα pathway. It has been reported that hypoxia can increase the expression of PPARα. In glioma primary cell cultures, a high grade of malignancy has been linked with higher levels of hypoxia which leads to altered peroxisomal number compared with low-grade gliomas (). Quantitative image analysis showed an increase in peroxisome and lipid droplet number under hypoxia, which correlated with up-regulation of peroxisomal β-oxidation enzymes such as ACOX1 and thiolase as well as PPARα (). The upregulation of hypoxia-inducible factor 2 alpha (e.g., in clear cell renal cell carcinomas) has however also been reported to promote peroxisome degradation  ADDIN EN.CITE (). A possible cross-talk mechanism between PPARα and the glucocorticoid (GC) pathway has been shown in HepG2 cells. Dexamethasone (a synthetic glucocorticoid) activates GC receptor-α (GRα) by eliciting a conformational change  ADDIN EN.CITE (). Activated GRα can directly regulate the expression of its target genes through binding promoters containing the GC response element (GREs). Target genes of GRα include those involved in fat, and protein metabolism and GRα can also influence gene expression by interfering with the activity of nuclear factor κB (NF-κB). The effect of different PPARα agonists on GC-induced mRNA expression of GR-inducible genes has been analyzed. In this study, dexamethasone treatment alone up-regulated mRNA expression levels of human placental alkaline phosphatase (hPAP) in HepG2 human hepatocyte cells. However, whilst treatment with WY 14643 (a PPARα agonist) alone had no effect on hPAP mRNA expression, the combination of dexamethasone and WY 14643 efficiently block hPAP gene expression, suggesting crosstalk between GR and PPARα signalling pathways  ADDIN EN.CITE (). Other possible activation pathways for PPARα include the involvement of protein kinase cascades, including Src (), p38  ADDIN EN.CITE (; ), ERK1/2  ADDIN EN.CITE (; ), MEK1 (), Ras  ADDIN EN.CITE (), and EGFR  ADDIN EN.CITE (). Moreover, GW7647 and other PPARα agonists affect calcium signalling in various cell types, including pancreatic β-cells  ADDIN EN.CITE () and eosinophils (). Finally, a GW7647-induced PPARα-binding region has also assigned to Sterol regulatory element-binding proteins (SREBP)-targets HMGCS1, HMGCR and LPIN1, suggesting cross-talk between PPARα and SREBP signalling (). 
Despite a large body of evidence linking PPARα signalling with a variety of other signalling pathways there are currently few reports on how this links to peroxisome homeostasis in humans. Although these data suggest the involvement of a variety of regulatory pathways in controlling transcription of PO proliferation related genes under different conditions there is currently a gap in understanding of precisely how this up-regulation of peroxisome genes is linked to up-regulation of proliferation  ADDIN EN.CITE (; ).
2.3. Other PPAR family members
With regards to peroxisome proliferation PPARα is currently the best-studied PPAR whilst the precise role of the other PPARs is less well-defined  ADDIN EN.CITE (; ). Several studies have implicated PPARβ and PPARγ as playing a role in a variety of different systems but how this is related to peroxisome proliferation is not clear. In an interesting study Diano and co-workers reported that the PPARγ agonist rosiglitazone increased peroxisome numbers and catalase levels in pro-opiomelanocortin neurons of the hypothalamus  ADDIN EN.CITE () and thereby altered redox potential and neuronal firing rates. PPARγ agonists were also reported to induce catalase activity in cortical neurons and astrocytes, providing higher anti-oxidant capability  ADDIN EN.CITE (). As PPARα activation is not normally associated with significant upregulation of catalase levels it is possible that this is a PPARγ-specific effect, caused by the presence of a PPARγ response element in the catalase gene  ADDIN EN.CITE (). Indeed, catalase induction by PPARγ may be independent of the process of peroxisome proliferation in individual cell types. Zanardelli and colleagues reported that astrocytes respond with an increase in peroxisome proliferation induced by the PPARγ antagonist G3335 but in parallel decreased catalase expression, whereas rosiglitazone as an PPARγ agonist, did not increase peroxisome abundance but induced catalase expression (). This implies that the peroxisome proliferation reported after G3335 administration is a compensatory response to antagonize the specific reduction in catalase levels caused by the inhibition of PPARγ. Thus it remains unclear if PPARy agonists generally enhance peroxisome abundance or specifically alter the expression of selected peroxisomal genes. Since PPAR-γ agonists have been considered as potential therapeutic agents for a wide range of neurological diseases, including neurodegenerative and demyelinating diseases  ADDIN EN.CITE (; ; ; ), it is a prerequisite to closely examine the proteomic alterations induced in peroxisomes in response to the drugs in order to avoid negative side effects by potentially impeding individual metabolic functions in the organelle. 
Another member of the PPAR family, PPARβ, has been shown to regulate fatty acid oxidation in cardiac tissue. Cardiac-specific deletion of PPARβ suppressed the expression of peroxisomal and mitochondrial fatty acid oxidases, resulting in myocardial lipid accumulation and reduced cardiac performance  ADDIN EN.CITE (). This fits with the cardio-protective role for peroxisomes first suggested in 1979 by Fahimi where an increase in catalase activity and peroxisome number was reported in heart-tissue of mice fed on an ethanol-rich diet (). A recent study added further complexity to this process by proposing a peroxisome/PPAR-feedback loop to regulate the levels of PPARγ and PPARβ (). It was demonstrated that PEX11α deficiency in mouse hearts interferes with the regulation of expression of PPARβ and PPARγ. The authors suggested that the development of cardiac dysfunction causes disruption of this loop-system, possibly by overload of long chain fatty acids in the system. This theory requires testing by using the PEX11α-/- mouse model with a high fat diet to investigate the risk of mild peroxisomal deficiency in cardiac dysfunction ().

2.4. PPAR Independent Mechanisms 
Even though there is compelling evidence that peroxisome proliferation is regulated by PPARs it is likely that other regulatory mechanisms also play a role. Indeed, peroxisome numbers have been shown to increase in response to external stimuli in a PPAR-independent manner. A plethora of chemical compounds (e.g. BM 15766 and 4-phenylbutyrate) were shown to induce peroxisome proliferation in mammalian cells (see  ADDIN EN.CITE () for details). BM 15766, an inhibitor of cholesterol biosynthesis at the 7-dehydrocholesterol-Δ7-reductase step, was shown to induce peroxisome proliferation without significantly increasing fatty acid β-oxidation enzymes levels, thus implying a PPARα-independent signal transduction. Phenylbutyrate was also shown to induce peroxisome proliferation in the absence of the nuclear receptor PPARα although a potential role for PPARγ has not been ruled out  ADDIN EN.CITE (; ; ). In a high content screen probing more than 15000 drugs, 10 new compounds were reported to induce peroxisome proliferation in HepG2 cells, which are supposed to be refractory to PPARα-mediated peroxisome proliferation (). Thus, there is increasing evidence for the existence of numerous PPARα independent pathways controlling peroxisome abundance, which could be exploited for therapeutic use in humans. For most of the chemicals described so far in the literature, the mechanism of action remains unknown  ADDIN EN.CITE (; ). However, unlike PPARα-ligands, which induce peroxisome proliferation in the absence of Pex11α, 4-phenylbutyrate does require Pex11α to induce peroxisome proliferation indicating the existence of alternative pathways involving different molecular players in order to control peroxisome abundance (). Besides the peroxisome proliferators reported up to now, other factors such as: growth factors, polyunsaturated fatty acids (e.g. arachidonic acid) and ROS have been shown to induce peroxisomal elongation (a pre-requisite for proliferation) in human cells  ADDIN EN.CITE (; ).
Another PPAR independent pathway has recently been discovered involving PPARγ coactivator-1α (PGC1-α) in human and mice  ADDIN EN.CITE (). Although, as the name suggests, the obvious receptor for PGC1-α would indeed by PPARγ this was excluded as the activating nuclear factor in this case. PGC1-α can activate gene expression by binding to other transcription factors such as NRF2  ADDIN EN.CITE (; ).
External signals such as growth factors can also induce peroxisome proliferation, suggesting the involvement of growth factor-dependent cascades such as mTOR. (). Indeed, the mTOR pathway has recently been linked with peroxisomes  ADDIN EN.CITE (). The mTOR protein forms two complexes, mTORC1 and mTORC2, each of which contains distinct components and signal through a different set of downstream effectors. A key function of mTORC1 is to coordinate nutrient availability with autophagy. When growth factors are present the action of mTORC1 ensures that autophagy is inhibited, whilst under starvation conditions, or in response to ROS, mTORC1 inhibition causes upregulation of autophagy (). The tuberous sclerosis complex (TSC) is a signalling node which represses mTOR1 signalling by inhibiting the activity of the small GTPase Rheb, leading to activation of autophagy  ADDIN EN.CITE (; ). Recently the peroxisomal localization of TSC1, TSC2 was reported  ADDIN EN.CITE (). The authors also suggest that the peroxisomal TSC functions as a signalling node which is able to repress mTORC1 and to induce autophagy when peroxisomal ROS production exceeds tolerable levels. 
3. Regulation of peroxisome proliferation by phosphorylation
3.1. Defining the peroxisomal phosphoproteome – the status quo
Protein modification by phosphorylation represents by far the most frequent mechanism to influence the activity/function of individual proteins and also whole signalling networks. In humans this dominance of phosphorylation over other secondary protein modifications is underlined by the sheer quantity of protein kinases in the human genome with more than 500 detected (). However, despite the obvious importance of phosphorylation-mediated signal transduction in cellular regulatory networks, our current knowledge about the impact of kinases/phosphatases on peroxisome abundance and function is astonishingly scarce (see Chapter by Warscheid & Platta, this issue). In principle, kinases and phosphatases can act on peroxisomes in two different ways: (1) Externally, cytosolic kinases/phosphatases can modify proteins at the surface of the organelle or other proteins in the cytosol which interfere with peroxisome regulation networks; (2) internally, kinases/phosphatases may be imported into the organelle matrix and target individual peroxisomal constituents to regulate the organelle’s metabolism. Metabolic changes may subsequently interfere with control systems for peroxisomal abundance.
Currently, the most extensive data on the peroxisomal status of phosphorylated proteins derives from the plant field. In a recent meta-analysis integrating the work of 27 phosphoproteomics studies from Arabidopsis thaliana the bulk of identified phosphopeptides were curated, filtered and associated to subcellular locations and functions (). About 1% of the curated phosphoproteome evaluated in this study comprise known peroxisomal constituents. Among those are enzymes for the organelle’s most prominent functions in plants – fatty acid β-oxidation (MFE2, 3-ketoacyl-CoA thiolase, Δ3,5, Δ2,4 enoyl-CoA isomerase, very long chain acyl-CoA synthetase), glyoxylate cycle (isocitrate lyase, citrate synthase) and ROS metabolism (catalase) but also peroxins involved in peroxisome biogenesis (Pex5, Pex14). 
In mammals, an integrating meta-analysis of the numerous phosphoproteome studies does not currently exist. However, phosphorylated peptides of peroxisomal matrix proteins like ACOX1, ACOX3, MFE2, peroxisomal 3-ketoacyl-CoA thiolase, DHAPAT and catalase were regularly identified in the human and mouse phosphoproteome screens. In terms of membrane associated proteins, the peroxins Pex1 and Pex14, and to a lesser extent Pex11β/γ are potentially phosphorylated  ADDIN EN.CITE (; ; ; ; ; ; ; ). In addition, phosphorylation of the two peroxisomal ABC transporters involved in fatty acid import, ABCD1 and ABCD3, has been described  ADDIN EN.CITE (). Interestingly, the two peroxisomal import receptors for matrix and membrane proteins, PEX5 and PEX19, are also among the repeatedly identified phosphorylated proteins   ADDIN EN.CITE (; ; ; ; ). 
In the yeast S. cerevisiae, a similar set of peroxisomal proteins were found to be phosphorylated including, amongst others, the peroxisomal β-oxidation enzymes Pox1 (ACOX) and Fox2 (MFE2) as well as the peroxins Pex5, Pex14, and Pex19 (). Hence, the phosphorylation of a subset of peroxisomal constituents, and presumably the underlying signalling networks regulating peroxisome physiology, seems to be conserved across species. Since both membrane as well as matrix proteins are phosphorylated, the phosphorylation events are likely catalyzed by internal but also external kinases and phosphatases. Remarkably, a significant number of phosphorylated targets represent peroxins, potentially linking kinase signalling systems to the regulation of peroxisome maintenance and proliferation. 

3.2. Towards understanding peroxin phosphorylation
Phosphorylation of Pex14, which belongs to the docking complex for the import shuttle receptors Pex5 and Pex7, was initially observed in the yeast species Pichia pastoris and Hansenula polymorpha around 15 years ago  ADDIN EN.CITE (; ). Besides its role in peroxisomal matrix protein import, HpPex14 was also found to contribute to the selective degradation of peroxisomes by pexophagy  ADDIN EN.CITE (). During methanol-induced proliferation of peroxisomes, phosphorylated Pex14 was not observed in significant amounts, whereas phosphorylation increased when peroxisome proliferation reached a plateau and pexophagy was subsequently induced  ADDIN EN.CITE (). In this respect, phosphorylation of Pex14 seems to counteract peroxisome proliferation and may in that way contribute to the regulation of cellular peroxisome abundance. The tail-anchored membrane protein ScPex15 is part of the exportomer complex for the peroxisomal shuttle receptor Pex5 and its deletion results in the accumulation of ubiquitinated Pex5 at peroxisomes, triggering pexophagy (). ScPex15 was the first phosphorylated peroxisomal protein described  ADDIN EN.CITE (). Its phosphorylation may also be involved in the regulation of peroxisome degradation and abundance. However, currently there is no experimental data on the functional significance of Pex15 phosphorylation. 
Pex11 (see section 4.1) is a key protein in the process of peroxisomal growth and division. Pex11 phosphorylation was described in the yeast species S. cerevisiae, P. pastoris and H. polymorpha at the homologous position S165/S173/S174, respectively  ADDIN EN.CITE (; ; ). Sc and PpPex11 phosphorylation increased under peroxisome proliferating conditions. Likewise, expression of phospho-mimicking mutants induced peroxisome proliferation, whereas expression of corresponding Pex11 mutants mimicking the dephosphorylated state lead to peroxisome clustering  ADDIN EN.CITE (; ). Beyond those observations there are no congruent reports on the effects of Pex11 phosphorylation: whereas Knoblach and Rachubinki suggested a role of ScPex11 phosphorylation in the formation of peroxisomes from the ER, Joshi and co-workers rather associated PpPex11 phosphorylation with the recruitment of the fission factor Fis1p. Phosphorylation of HpPex11, however, neither influenced peroxisome fission nor Pex11 localization (). Currently no elaborate studies on the phosphorylation of mammalian Pex11 exist (note that the homologous residue to yeast, S165/173/174, only appears to be conserved in Pex11α). Modification of a potential phosphorylation site at the N-terminal, cytosolic part of Pex11β had no effect on peroxisome proliferation (). Animals and fungi likely developed alternative strategies for the control of Pex11 activities, and future studies have to reveal to what extent kinases interfere with the proliferative function of Pex11 and its isoforms. In addition to Pex11, both the peroxisomal (and mitochondrial) division factor DLP1/Drp1 and its membrane adaptor Mff (see sections 4.4 and 4.6) (Figs. 2 & 3) have been shown to be phosphorylated: Human DLP1 can be phosphorylated at Ser616 or 637, promoting or opposing mitochondrial fission, respectively  ADDIN EN.CITE (; ; ; ) If peroxisome fission is influenced by these post-translational modifications in a similar way is unknown. DLP1 has also been reported to be potentially regulated by ubiquitination and sumoylation  ADDIN EN.CITE (; ). In a recent screen for targets of AMP-activated protein kinase (AMPK), Mff was reported to be phosphorylated at S129 and S146 by AMPK  ADDIN EN.CITE (). Moreover, three additional AMPK-independent phosphorylation sites were found  ADDIN EN.CITE (). A functional significance for Mff phosphorylation, however, awaits further clarification.

3.3. Kinases and phosphatases in peroxisome biogenesis and metabolism
Beyond these reports on the phosphorylation of peroxisomal proteins, the identification of kinases and phosphatases regulating peroxisomal metabolism, and in particular biogenesis, is a demanding task. Currently, the number of kinases reported to modulate peroxisomal physiology is limited, and associated kinases or phosphatases have been only reported from plants and fungi. In a systems biology approach, Saleem and coworkers (2008) compared the effect of 249 kinase and phosphatase gene deletions on expression of a GFP-coupled 3-ketoacyl-CoA thiolase reporter as well as peroxisome number and morphology under peroxisome repressing and inducing nutrients in S. cerevisiae. The authors deciphered a complicated network of numerous signalling molecules influencing different stages of the transition from a peroxisome repressing (glucose) to peroxisome proliferating state (oleate). With a focus on peroxisome biogenesis the signalling proteins were found to modulate peroxisome numbers or peroxisome morphology  ADDIN EN.CITE (), implying that kinases/phosphatases may regulate peroxisome abundance at the transcriptional level or may directly interfere with the process of fission at the peroxisome itself. Pho85p, one of the kinases which showed an impact on peroxisome repression but also peroxisome morphology, was subsequently identified as a protein with an impact on Pex11 phosphorylation (). However, it remains unclear if Pho85p acts directly on Pex11 or interferes with a higher order signalling network. In a follow-up study, Aitchison and coworkers further observed a significant number of kinases and phosphatases among the phosphorylated targets after oleate-induction, implying that peroxisomes are controlled by kinase cascade systems  ADDIN EN.CITE (). 
In opposition to peroxisome proliferation, the process of pexophagy mitigates the control of peroxisome numbers in response to changing environmental conditions. In the yeast S. cerevisae ATG36 was recently described as a docking factor, which after binding to Pex3 links peroxisomes to the autophagic apparatus subsequently leading to organelle degradation (). Phosphorylation of ATG36 by the kinase Hrr25p is required for the interaction with ATG11, a downstream pexophagy-mediating protein  ADDIN EN.CITE (), suggesting that both peroxisome proliferation and degradation are under tight control of kinase signalling networks in yeast. 
The place of action of ScPho85p and ScHrr25p, directly at peroxisomes or in the surrounding cytosol, has not yet been determined. In contrast, two kinases from Arabidopsis thaliana, the Calcium-dependent protein kinases 1 (CDPK1) and glyoxysomal protein kinase 1 (GPK1), were localized at the peroxisomal membrane  ADDIN EN.CITE (; ). However, neither appears to be associated with the regulation of peroxisome abundance. AtCDPK1 mediates jasmonic acid induced pathogen resistance (). As jasmonic acid synthesis is partially peroxisomal (), AtCDPK1 may be involved in the regulation of the organelle’s metabolic activities. No function could be attributed to AtGPK1, but as the enzymatic domain of the protein faces the peroxisomal matrix, a role in metabolic regulation is likely  ADDIN EN.CITE (). 
Phosphatases have also been shown to localize to Arabidopsis peroxisomes. MAP kinase phosphatase 1 harbors a weak peroxisomal targeting sequence 1 (PTS1), and targets to peroxisomes under several stress conditions  ADDIN EN.CITE (). Under stress the enzyme may be involved in controlling peroxisomal ROS production or the synthesis of jasmonic acid. Serine/threonine-specific phosphoprotein phosphatases 2A (PP2A) are highly conserved, heterotrimeric proteins consisting of a scaffolding A, regulatory B and a catalytic C subunit (). In Arabidopsis the regulatory subunit Bθ bears a PTS1 and is imported into peroxisomes (). Very recently it was shown that the complete PP2A holoenzyme localizes to peroxisomes, highlighting the organelle’s unique capacity to import fully assembled protein complexes in a piggyback system. Functionally, PP2A was reported to elevate peroxisomal β-oxidation but no impact on total peroxisome abundance was observed  ADDIN EN.CITE (). In summary, all kinases and phosphatases, which were shown to be imported into peroxisomes, appear to be involved (as perhaps expected) in metabolic control of the organelle. However, as discussed above (see section 2.4), a recent study from mammals reported components of the mTORC1 signalling node localize to the surface of peroxisomes and can suppress mTORC1 activity in response to ROS  ADDIN EN.CITE (). Thus, metabolites produced in the peroxisomal matrix may reciprocally influence higher level cellular signalling pathways. In this respect, phosphorylation of matrix enzymes may fine tune the production of metabolites in peroxisomes, which can act as signalling molecules in the organelle’s surroundings. Using such signalling circuits, kinase-controlled signalling systems may reciprocally control transcription factors which regulate peroxisome abundance/proliferation (Fig. 1). Indeed, PPARα can be phosphorylated at multiple sites  ADDIN EN.CITE (). Several kinase systems including protein kinase C, MAPKp38 or AMPK-mediated signalling networks are involved in phosphorylation-dependent up- or down-regulation of PPARα transcriptional activity  ADDIN EN.CITE () Snf1p, a homolog of AMPK in S. cerevisiae  ADDIN EN.CITE (), is involved in the regulation of peroxisomal gene expression and proliferation by targeting the transcription factor Adr1p. Thus, cytosolic signalling networks may be activated by peroxisome-derived metabolites to subsequently control transcription factors mediating peroxisome proliferation and thereby closely regulate peroxisome abundance and activities (Fig. 1). In this respect it will be challenging to identify the signals and their correspondent mediator proteins from the organelle to the higher level control systems.

In addition to phosphorylation, other posttranslational protein modifications might influence peroxisome dynamics. Protein ubiquitination has been shown to influence peroxisome protein import and autophagy by targeting Pex5: mono-ubiquitination at Cys11 leads to recycling of the PTS1-import receptor from the peroxisomal membrane back into the cytosol while poly-ubiquitination marks peroxisomes for degradation by autophagy  ADDIN EN.CITE (). In addition, ubiquitination of other peroxins has been described to influence protein import and degradation of peroxisomes  ADDIN EN.CITE (; ; ; ) (see Chapter by Platta & Eggeling, this issue). Interestingly, the ubiquitinatable Cys11/10 of Pex5 was shown to be redox-sensitive in humans and P. pastoris  ADDIN EN.CITE (; ). Despite this analogy, the function of Cys11 oxidation was controversially described in both species: In P. pastoris homodimerization of Pex5 by Cys10 disulfide-bridge formation was reported to facilitate cargo loading in the cytosol and respective reduction of Cys10 in the peroxisome matrix to trigger release of the PTS1-protein. Thus, a more oxidizing redox state in the cytosol would ameliorate peroxisomal matrix protein import and peroxisome biogenesis. In contrast, in human embryonic fibroblasts an increase in the cytosolic redox state and accompanying Cys11 oxidation decreased PTS1-dependent protein import into peroxisomes. Thus, cellular oxidative stress would block peroxisome biogenesis and thus production of H2O2 by peroxisomal oxidases. These contradicting results might be due to species differences but may be also caused by different experimental set-ups used in the two studies. Nevertheless, both publications indicate that peroxisome function is controlled by an increasing spectrum of post-translational protein modifications illustrating a complex network of regulatory cellular networks.

4. Peroxisomal growth and division in mammalian cells
4.1. The Pex11p family - membrane deformation and more




Fig. 2. Model of peroxisomal growth and division in mammalian cells. 
Peroxisome proliferation in mammalian cells involves a well-defined sequence of morphological changes, including membrane elongation (growth), constriction, and final membrane scission. Pex11β initiates membrane remodelling and the formation of a tubular membrane extension at pre-existing peroxisomes (see section 4.1). (a) Peroxisomal membrane remodelling via Pex11 is induced by the insertion of amphipathic, N-terminal helices into one leaflet of the lipid bilayer causing membrane asymmetry and bending  ADDIN EN.CITE (; ). Oligomerisation is required for Pex11β function in membrane elongation and may as well stabilize membrane tubules. The growing membrane extension acquires a specific set of peroxisomal membrane proteins (e.g. Pex11β, Fis1), before it constricts and import of predominantly newly synthesized matrix proteins is initiated (). Pex11β and the Mff-DLP1 complex concentrate at the sites of constriction, possibly driven by alterations in membrane curvature. The role of Fis1 is currently unclear. (b) Cytosolic DLP1 is recruited by the membrane receptor Mff. After targeting, DLP1 self-assembles into large ring-like structures. (c) Pex11β acts as a GTPase activating protein on DLP1  ADDIN EN.CITE (). GTP hydrolysis by DLP1 leads to constriction of the DLP1 ring and results in final membrane scission. 

In recent years considerable progress has been made in the understanding of Pex11β function and importance for human health. Pex11β, which is widely expressed in mammalian tissues, has a recognized and important role in peroxisomal growth and division. It remodels and elongates peroxisomal membranes in the initial phase of peroxisomal fission  ADDIN EN.CITE (; ; ). This remarkable biophysical property of Pex11β depends on (i) its ability to interact with membrane lipids  ADDIN EN.CITE (; ; ; ), (ii) amphipathic helices in the N-terminal domain () and (iii) self-interaction to form homo-dimeric/oligomeric complexes  ADDIN EN.CITE (; ; ; ) (Fig. 3). 
Several Pex11 family members have been shown to exhibit membrane remodeling activity in vitro, which depends on the intactness of the amphipathic helices (Fig. 2) which are supposed to mediate interaction with membrane phospholipids  ADDIN EN.CITE (; ). Deletion of helices or insertion of helix-breaking proline residues inhibits Pex11β-mediated peroxisome elongation and oligomerisation in mammalian cells  ADDIN EN.CITE (; ) (Figs. 2 & 3). These findings suggest that Pex11β acts as a scaffold protein, which associates with membrane phospholipids via its N-terminal amphipathic helices to remodel and deform the peroxisomal membrane. It may also stabilize membrane tubules via oligomerisation, which is required for Pex11β function in membrane elongation. In line with this, Pex11β first initiates the formation of nose-like membrane protrusions at spherical peroxisomes, which further elongate, with Pex11β moving into those elongating structures  ADDIN EN.CITE (; ). Pex11β is then supposed to initiate (or contribute to) the formation of constriction sites, in which it accumulates (see below) (Fig. 2). Although Pex11β has no intrinsic membrane scission activity, it is supposed to assemble key components of the peroxisomal division machinery. Those include the membrane receptor proteins Mff and Fis1 (see section 4.6), which were reported to interact with Pex11β  ADDIN EN.CITE (; ; ) (Figs. 2 & 3). They recruit the dynamin-related GTPase DLP1/Drp1 to the peroxisomal membrane which acts in membrane scission to divide peroxisomes (see section 4.4) (Fig. 2). A new and crucial function of yeast Pex11p and Pex11β in the final step of peroxisomal fission was very recently identified  ADDIN EN.CITE (). Hansenula polymorpha Pex11p was shown to be necessary for the function of the dynamin-like GTPase HpDnm1p (DLP1) in vivo and to physically interact with Dnm1p via conserved amino acid stretches in the N-terminal domain. Mutation of the conserved amino acids inhibited this interaction and compromised peroxisomal fission in both yeast and mammalian cells. It was further shown that Pex11p functions as a GTPase activating protein (GAP) for Dnm1p/DLP1 at the peroxisomal membrane (Fig. 2). These findings explain why expression of Pex11β in mammalian cells promotes the formation of a large number of tiny, spherical peroxisomes: its expression first induces peroxisomal membrane elongation (growth of the peroxisomal compartment) and assembly of the division machinery, and it then accelerates peroxisomal division by activating DLP1 GTPase activity, driving membrane scission.
It should be emphasized that Pex11β-mediated membrane elongation results in the formation of a new peroxisomal membrane compartment, which imports newly synthesized peroxisomal matrix proteins (). In this respect, peroxisome division is an asymmetric rather than a symmetric process. Peroxisome formation by growth and division gives rise to new peroxisomes and contributes to the rejuvenation of the peroxisomal compartment in the cell  ADDIN EN.CITE (). 




Fig. 3. Domain architecture of factors implicated in peroxisomal fission.
Critical residues discussed in the text are highlighted. N, N-terminus; C, C-terminus; TMD, transmembrane domain; TPR, Tetratricopeptide-repeat-like; Coil, predicted coiled-coil; GED, GTPase effector domain; B-ins, B-insert, GST-N/C, Glutathione-transferase domain; Hd1, hydrophobic domain 1; * indicates modification site.

4.2. Pex11 deficiency
Among the mammalian Pex11p, only loss of Pex11β has been linked to a pathology associated with peroxisome biogenesis disorders (PBDs)  ADDIN EN.CITE (; ; ). Knockout of Pex11β in mice results in neonatal lethality and several defects reminiscent of PBDs (e.g., developmental delay, hypotonia, neuronal migration defects and neuronal apoptosis) () (see Chapter by Wanders & Waterham, this issue). This is in contrast to loss of Pex11β function in humans  ADDIN EN.CITE (), which results in a milder pathological phenotype (for recent review see (). In contrast to classical PBDs, peroxisomal biochemical abnormalities were not detected, but peroxisomes in skin fibroblasts were enlarged and elongated supporting a defect in peroxisome division or proliferation. A proposed function of HsPex11β in matrix protein import (due to mislocalisation of a matrix protein in patient fibroblasts) was not confirmed (). 
Knockout of Pex11α in mice initially revealed no obvious phenotypic alterations (). However, Pex11α deficiency was recently associated with impaired fatty acid metabolism, and non-alcoholic fatty liver under high-fat diet and fasting conditions  ADDIN EN.CITE () as well as aggravated renal interstitial lesions  ADDIN EN.CITE (). How the molecular function of Pex11α is linked to the pathophysiological alterations has yet to be determined. Patients with a defect in Pex11α have not yet been reported, whereas seven additional patients with null mutations in the PEX11β gene have been identified  ADDIN EN.CITE (). 

4.3. Constricting peroxisomes prior to fission
Following elongation the next process to occur in peroxisomal division is constriction of the membrane prior to final membrane scission (Fig. 2). Membrane constriction is necessary, as the DLP1 ring has a restricted diameter and cannot encircle a whole organelle. For example, tubular mitochondria, which also depend on DLP1 for division, are generally ~300 nm in diameter  ADDIN EN.CITE () whilst mitochondrial constriction sites have been measured at around 110 nm which correlates with the diameter of the DLP1 ring  ADDIN EN.CITE (). Similar observations have been made for peroxisomes  ADDIN EN.CITE (). Peroxisome constriction occurs at multiple, specific foci, periodically distributed along elongated peroxisomes  ADDIN EN.CITE (; ). It is still unclear how the constriction sites are formed and how their position is defined. As constrictions on elongated peroxisomes are observed in the absence of DLP1 (or its membrane adaptor Mff), these key components for division are not considered essential for constriction  ADDIN EN.CITE (; ). However, it is known that Pex11β accumulates at constriction sites  ADDIN EN.CITE () and that manipulation of Pex11β blocks constriction ()  ADDIN EN.CITE (). Very recently, membrane constriction of liposomes was observed in vitro after reconstitution with recombinant Pex11β () indicating that Pex11β itself may mediate peroxisomal membrane constriction. It is possible that Pex11β, which has lipid-interacting properties (see above), generates high-curvature membrane foci in conjunction with specific phospholipids. If Pex11β can achieve this on its own or requires interaction and support of other fission factors such as Mff, Fis1 or DLP1 is currently unknown (Figs. 2 & 3). 
Recently, mitochondrial fission in yeast and mammals has been described to be supported by the ER at ER-mitochondria contact sites in conjunction with F-actin assembly  ADDIN EN.CITE (; ; ). Yeast mitochondria are wrapped by ER causing constriction to a size approximately suitable to fit a Dnm1/Drp1 ring (around ~138 nm)  ADDIN EN.CITE (). In mammalian cells, DLP1 puncta formation at mitochondrial division sites (which are spatially linked to ER-mitochondria contact sites) is increased when the ER-localized inverted formin 2 (INF2) is over-expressed and decreased when INF2 is reduced  ADDIN EN.CITE (). INF2 may not be essential for this process, or not all fission reactions may require INF2 and may be ER-independent, but it does appear to facilitate it. INF2-mediated mitochondrial fission requires actin and myosin II, with actin proposed to polymerize at the interface between the ER and mitochondria. A mechanism is suggested whereby INF2-mediated actin polymerization leads to myosin II recruitment and constriction at the fission site, enhancing subsequent DLP1 accumulation and fission (). The role of the ER or actin assembly in peroxisomal fission in mammalian cells is presently unclear but as there is also an intimate relationship between peroxisomes and the ER (for review see (), a similar mechanism could be employed.

4.4. Peroxisomal membrane scission
4.4.1. DLP1/Drp1 – the fission GTPase
Dynamin-like/related protein 1 (DLP1/Drp1), a large GTPase of the dynamin superfamily  ADDIN EN.CITE (; ), is the main mediator of both peroxisomal and mitochondrial fission in mammals () (Figs. 2 & 3). DLP1 is mainly found in the cytoplasm but assembles, as required, into ring-like complexes which encircle constricted organelles  ADDIN EN.CITE (; ). DLP1 appears to use a similar mechanism to classical dynamin in that it is recruited to the constriction sites on the membrane in the monomeric form. Then GTP hydrolysis drives polymerisation and membrane constriction by inducing a hinge-like conformational change, a “power-stroke” (). The size of the extended DLP1 ring is much larger than that of classical dynamin and strikingly similar to the size of the constriction sites for mitochondria (). 
Like classical dynamin, DLP1 is made up of a mechanochemical core with a GTPase, middle, and GTPase effector domain (GED) (Fig. 3). An essential coiled-coil domain in the C-terminus which directs mitochondrial targeting appears to allow DLP1 to associate with mitochondria but localization to specific foci is thought to require adaptor proteins (see below). The C-terminal GTPase effector domain also plays a role in stimulating GTPase activity and formation of higher order complexes  ADDIN EN.CITE (). In place of the pleckstrin homology domain in dynamin, DLP1 contains an unstructured variable domain, whose function is not yet fully resolved  ADDIN EN.CITE ().
The crystal structure of human DLP1 was recently solved revealing similarities with dynamin but suggesting a double rather than single filament (). Other data in this study suggested that the affinity of DLP1 monomers for membranes is low, highlighting the importance of multimerization and/or interaction with other membrane adaptors to secure DLP1 to the membrane (Fig. 2). In addition to multimerization and interaction with membrane adaptors, DLP1-mediated fission requires GTP hydrolysis. GTPase or oligomerisation-deficient mutants or reducing levels of DLP1 result in highly elongated, segmented peroxisomes (and mitochondria), which still maintain constriction sites but cannot divide  ADDIN EN.CITE (; ). Over-expression of DLP1 has no impact on peroxisome number () presumably because an increase in the amount of DLP1 present in the cytoplasm does not directly lead to more recruitment to peroxisomes. 
During the final scission process the DLP1 ring is predicted to potentially constrict by ~60 nm from an initial size of ~ 139 nm to a final width of ~77 nm  ADDIN EN.CITE () (Fig. 2). In the dynamin field there is some debate as to the level of ring constriction required to separate membranes and whether constriction alone is sufficient or if there may also be a role for additional pulling forces  ADDIN EN.CITE (; ). Membrane tension and rigidity may also have a strong impact on the kinetics of the fission reaction, essentially meaning that the composition of the membrane could have an impact on the constriction radius of dynamin (or DLP1) required to achieve fission (). For example, in neurons which have a membrane particularly rich in polyunsaturated acyl chains, dynamin-dependent fission during endocytosis is very fast  ADDIN EN.CITE (; ). As there are potential differences in the lipid composition of the peroxisomal and mitochondrial membranes  ADDIN EN.CITE (; ) this may result in slightly different kinetics of DLP1 ring constriction. Furthermore, the fatty acid composition of whole cells and peroxisomes can be affected by growth conditions. When the yeast P. pastoris was cultivated on oleic acid, the latter became the predominant fatty acid in phospholipids from total cell and peroxisomal extracts  ADDIN EN.CITE (). Thus, certain fatty acids may not only be utilized as an appropriate carbon source but also as a building block for complex membrane lipids, which may in turn modulate organelle membrane division. In line with this, addition of docosahexaenoic acid (DHA) to fibroblasts isolated from patients that carry defects in peroxisomal fatty acid β-oxidation induced peroxisome proliferation and restored a typical peroxisomal phenotype  ADDIN EN.CITE (; )

4.5. DLP1 deficiency
Dysfunction of DLP1 and loss of mitochondrial fission-fusion balance has been implicated in several neurological and cardiovascular diseases (). The first patient with a lethal defect in DLP1 function has been reported  ADDIN EN.CITE (). Loss of DLP1 function was due to a heterozygous, dominant-negative missense mutation in the DLP1 middle domain  ADDIN EN.CITE () which inhibits oligomerization  ADDIN EN.CITE () (Fig. 3). Patient cells displayed abnormal elongated peroxisomes and mitochondria (for detailed review see (). Similar to the Pex11β patients, metabolic biomarkers for peroxisome disorders were not grossly altered indicating a defect in peroxisome membrane dynamics and division.
Recent studies with mdivi-1 (mitochondrial division inhibitor), a small molecule, selective inhibitor of DLP1  ADDIN EN.CITE (; ), revealed that inhibition of DLP1 exerts protective effects in heart and cerebral ischemia-reperfusion models and provides neuroprotection in Parkinson models  ADDIN EN.CITE (; ). Mdivi-1 prevented mitochondrial fission, loss of mitochondrial membrane potential, and cell death in acute brain injury. Furthermore, mdivi-1 attenuated neurotoxicity and restored pre-existing striatal dopamine release deficits in animal models for Parkinson disease  ADDIN EN.CITE (). These findings highlight a potential novel therapeutic avenue for neurodegenerative disorders and heart disease. The effect of mdivi-1 on peroxisomes has not been studied in detail. It is however almost certain that mdivi-1 will inhibit peroxisomal fission as well, which would warrant further investigation. It is currently unclear if an inhibition of peroxisomal fission is protective and exerts positive effects under certain disease conditions.

4.6. The DLP1 recruitment factors
A number of adaptor proteins can recruit DLP1 to the mitochondrial and peroxisomal membrane in mammalian cells. Those include the C-tail anchored membrane proteins Fis1 (Fission factor 1) and Mff (Mitochondrial fission factor), which are found on both mitochondria and peroxisomes  ADDIN EN.CITE (; ) (Figs. 2 & 3). Fis1 possesses an N-terminal tetratricopeptide repeat (TPR) domain, whereas Mff has a central coiled-coil and two short repeat motifs within its N-terminal domain (Fig. 3). Mff is only found in metazoans, but homologs of Fis1 contribute to peroxisomal and mitochondrial fission in yeast and plants  ADDIN EN.CITE (; ; ) .Yeast and plants use additional, organism-specific adaptor proteins to recruit Dnm1/DRP (e.g. S. cerevisae Mdv1 and Caf4, two WD40 domain-containing adaptor proteins, or PMD1 (Peroxisomal and Mitochondrial Division Factor 1) in plants). In addition, MiD49 and MiD51/MIEF1, two N-terminally anchored mitochondrial membrane proteins, have been found to recruit DLP1 to mitochondria  ADDIN EN.CITE (; ). As for Mff, homologs of MiD proteins are not found in yeast. Although MiD49 and MiD51 do not localize to peroxisomes, their overexpression can deplete DLP1 from the cytosol, thus interfering with peroxisomal division and inducing peroxisome elongation  ADDIN EN.CITE (). It has been reported that Mff can bind DLP1 independently of Fis1 () and that MiD proteins (MiD49 and MiD51) work with DLP1 to promote fission independently of Fis1 and Mff  ADDIN EN.CITE (). Although there is currently conflicting evidence on the role of these adaptor proteins in mitochondrial and peroxisomal dynamics, it appears that they work together to promote fission  ADDIN EN.CITE (), e.g. by recruitment and activation of DLP1. 
As indicated above, the precise molecular function of Mff is not entirely clear but it is generally thought to play a major role in recruiting DLP1 to peroxisomes and mitochondria (although other proteins can perform this function). The first patients with a truncation mutation in the Mff gene were recently reported  ADDIN EN.CITE (), which is supposed to remove the C-terminal transmembrane domain (Fig. 3). In line with this, patient skin fibroblasts showed elongated mitochondria and peroxisomes. The patients exhibited developmental delay with initial diagnosis of mitochondrial encephalopathy. Similar to the DLP1 and Pex11β patients, metabolic parameters of peroxisomes and mitochondria were not or only slightly altered indicating a defect in organelle membrane dynamics and division ()
Mff can also potentially stimulate the GTPase activity of DLP1, although Mff still localises to mitochondrial constriction sites in the absence of DLP1, and the constriction sites themselves are generated independently of Mff (). In a recent study, Itoyama and colleagues provided evidence that knockdown of Mff reduced DLP1 association with peroxisomes  ADDIN EN.CITE (). By co-expression with Pex11β they suggested that Mff acts downstream of Pex11β-mediated elongation and also detected a trimeric DLP1-Mff-Pex11β complex with interaction between Pex11β and DLP1 being dependent on Mff. Fis1 however was not present and did not impact on this complex, although it has been reported to play a role in peroxisome dynamics  ADDIN EN.CITE (; ; ; ). Kobayashi and colleagues identified a complex at peroxisomes which included Pex11β, DLP1 and Fis1  ADDIN EN.CITE (). They also demonstrated that the binding between Pex11β and Fis1 involves the C-terminal region of Pex11β, whilst the N-terminal region of Pex11β is required for homo-dimerisation and induction of peroxisome proliferation (see section 4.1) (Fig. 3). Surprisingly, Fis1 (-/-) cells have minimal mitochondrial fission defects, and silencing of Fis1 had little effect on peroxisome morphology  ADDIN EN.CITE (; ). Despite this, Fis1 does play a role in mitochondrial fission and assembles with the other fission proteins at ER-MITO contact sites. Shen and colleagues attributed this to Fis1 playing a more specific role in stress-induced mitochondrial fission coupled with degradation. This suggests that, as for mitochondria, there are potentially several distinct complexes which can stimulate peroxisomal fission, which may be employed under different conditions.
Recently, the potential glutathione S-transferase GDAP1 (Ganglioside induced differentiation associated protein 1) was reported to localize to both peroxisomes and mitochondria and to influence their dynamics and division  ADDIN EN.CITE () (Fig. 3). The exact role of GDAP1 in peroxisomal and mitochondrial fission is not yet clear but it is able to promote fission and requires DLP1 and Mff to act on mitochondria and peroxisomes  ADDIN EN.CITE (; ). Mutations in GDAP1 have been associated with Charcot-Marie-Tooth disease, the most common inherited peripheral neuropathy. N-terminal autosomal recessively inherited disease mutations which impact on mitochondrial fission do not alter peroxisomal fission suggesting differences in mechanism  ADDIN EN.CITE (; ) . Recent studies have suggested a role for GDAP1 and other GDAP1-like proteins in the response to oxidative stress associated with an increase in reduced glutathione levels  ADDIN EN.CITE () or a possible function in organelle movement via interaction with organelle trafficking proteins RAB6B and caytaxin  ADDIN EN.CITE () In addition, a role for GDAP1 in mitochondria-ER interactions is suggested  ADDIN EN.CITE (; ).

5. Conclusions and perspectives
Although our understanding of the mechanisms by which peroxisomes proliferate is steadily increasing (see section 4 and Fig. 2), this is not matched by our knowledge on how the division process is linked to extracellular signals (Fig. 1). In mammals, it is clear that a key player specifically facilitating peroxisome proliferation is Pex11β ()  ADDIN EN.CITE (). This unique protein is not only involved in membrane remodelling prior to division; it is also likely important for the recruitment of the other fission adapters to the division site and also in the activation of DLP1. This importance is most obviously reflected when Pex11β is over-expressed, which causes first elongation and then subsequent division of peroxisomes (). It would therefore appear that Pex11β would be an ideal target for signalling pathways which have the ultimate aim of increasing peroxisome number. So far this has not been reflected in transcriptomic studies with human and rodent cells using peroxisome proliferators to stimulate peroxisomal function or number (see section 2). These studies have suggested that the majority of genes which are up-regulated following different stimuli are those related to peroxisomal enzyme activity or, interestingly, Pex11α  ADDIN EN.CITE (). The precise function of Pex11α is less clear but may be linked to more specialized functions such as in lipid homeostasis or membrane contact sites  ADDIN EN.CITE (; ). Further clarification of the role of the different Pex11 isoforms is required to deduce how transcriptional signal cascades produced by environmental stimuli correlate with an increase in peroxisomal number. Despite an in-depth, mechanistic understanding of factors involved in peroxisome-related signalling, such as the PPARs (see section 2 and Fig. 1), there is still some uncertainty as to how signal flux through such pathways leads to an increase in peroxisome number, most notably in humans. 
Besides Pex11β there are several other factors whose activity could be modified to control peroxisome proliferation. Most notably DLP1 which can be modified in multiple ways (see section 4 and Fig. 3) to regulate membrane association () DLP1 regulation during peroxisomal division (e.g. by phosphorylation) has not been fully explored but this would be a potential control point which could be activated by different kinases in response to environmental cues. 
Deficiencies in peroxisome proliferation have been associated with a variety of disease states, including liver diseases and neurological dysfunction, as well as cellular ageing  ADDIN EN.CITE (; ; ). A clear understanding of the mechanisms and signalling pathways that control peroxisome plasticity could allow modulation of peroxisome abundance to improve cellular function in health and disease.
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